Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Guest Editorial
  • Published:

A Brain Capital Grand Strategy: toward economic reimagination

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Overview of the Brain Capital Model.
Fig. 2: Potential components of the Brain Capital Index.

References

  1. Lund S, Manyika J, Segel LH, Dua A, Hancock B, Rutherford S, et al. The future of work in America: people and places, today and tomorrow. Washington, DC: McKinsey Global Institute; 2019. https://www.mckinsey.com/featured-insights/future-of-work/the-future-of-work-in-america-people-and-places-today-and-tomorrow.

  2. OECD NAEC. A systemic resilience approach to dealing with Covid-19 and future shocks. http://www.oecd.org/coronavirus/policy-responses/a-systemic-resilience-approach-to-dealing-with-covid-19-and-future-shocks-36a5bdfb/ (2020). Accessed 2020.

  3. Dash P, Dorling G, Rutter K-A, Linzer K, Ramdorai A, Remes J, et al. How prioritizing health could help rebuild economies. https://www.mckinsey.com/industries/healthcare-systems-and-services/our-insights/how-prioritizing-health-could-help-rebuild-economies?cid=other-eml-alt-mgi-mck&hlkid=e9526e2a6246477bbe55addf554e18c0&hctky=12203802&hdpid=1f9c67f8-fc5f-4357-b3fd-c4ed217bbfc6 (2020). Accessed 2020.

  4. Chisholm D, Sweeny K, Sheehan P, Rasmussen B, Smit F, Cuijpers P, et al. Scaling-up treatment of depression and anxiety: a global return on investment analysis. Lancet Psychiatry. 2016;3:415–24.

    PubMed  Google Scholar 

  5. Holmes EA, O’Connor RC, Perry VH, Tracey I, Wessely S, Arseneault L, et al. Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020;7:547–60.

    PubMed  PubMed Central  Google Scholar 

  6. Blazer D. Social isolation and loneliness in older adults-a mental health/public health challenge. JAMA Psychiatry. 2020;77:990–1.

    PubMed  Google Scholar 

  7. Vahia IV. COVID-19, aging and mental health: lessons from the first six months. Am J Geriatr Psychiatry. 2020;28:691–4.

    PubMed  PubMed Central  Google Scholar 

  8. Orben A, Tomova L, Blakemore S-J. The effects of social deprivation on adolescent development and mental health. Lancet Child Adholesc Health. 2020;4:P634–40.

    Google Scholar 

  9. Steenblock C, Todorov V, Kanczkowski W, Eisenhofer G, Schedl A, Wong ML, et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis. Mol Psychiatry. 2020;25:1611–7.

    CAS  PubMed  Google Scholar 

  10. Milner A, King TL, LaMontagne AD, Aitken Z, Petrie D, Kavanagh AM. Underemployment and its impacts on mental health among those with disabilities: evidence from the HILDA cohort. J Epidemiol Community Health. 2017;71:1198–202.

    PubMed  Google Scholar 

  11. Koralnik IJ, Tyler KL. COVID-19: a global threat to the nervous system. Ann Neurol. 2020;88:1–11.

    CAS  PubMed  Google Scholar 

  12. Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak T, Tenorio E, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;7:P875–82.

    Google Scholar 

  13. Mak IW, Chu CM, Pan PC, Yiu MG, Chan VL. Long-term psychiatric morbidities among SARS survivors. Gen Hosp Psychiatry. 2009;31:318–26.

    PubMed  PubMed Central  Google Scholar 

  14. Abbott R. The reasonable robot: artificial intelligence and the law. London: Cambridge University Press; 2020. https://doi.org/10.1017/9781108631761.

  15. Bavel JJV, Baicker K, Boggio PS, Capraro V, Cichocka A, Cikara M, et al. Using social and behavioural science to support COVID-19 pandemic response. Nat Hum Behav. 2020;4:460–71.

    PubMed  Google Scholar 

  16. Wilson M, Wilkerson B. Brain health + brain skills = brain capital: final report of the global business and economic roundtable on addiction and mental health. Toronto, Ontario: Mental Health International; 2011. http://www.mentalhealthroundtable.ca/report/MHR_FinalReport.pdf.

  17. Ibáñez A, Sedeño L, García AM. Neuroscience and social science: the missing link. Switzerland: Springer; 2017. https://doi.org/10.1007/978-3-319-68421-5.

  18. Ibáñez A, García AM. Contextual cognition: the sensus communis of a situated mind. Switzerland: Springer; 2018. https://doi.org/10.1007/978-3-319-77285-1.

  19. Ibanez A, Kotz SA, Barrett L, Moll J, Ruz M. Situated affective and social neuroscience. Front Hum Neurosci. 2014;8:547.

    PubMed  PubMed Central  Google Scholar 

  20. Cosmelli D, Ibáñez A. Human cognition in context: on the biologic, cognitive and social reconsideration of meaning as making sense of action. Integr Psychol Behav Sci. 2008;42:233.

    PubMed  Google Scholar 

  21. Smith E, Au R, Mosse M, Lavretsky H, Forbes M, Eyre HA. Rebooting late-life mental health innovation and entrepreneurship with convergence science. Am J Geriatr Psychiatry. 2020;28:591–6.

    PubMed  Google Scholar 

  22. Beddington J, Cooper CL, Field J, Goswami U, Huppert FA, Jenkins R, et al. The mental wealth of nations. Nature. 2008;455:1057–60.

    CAS  PubMed  Google Scholar 

  23. Lim SS, Updike RL, Kaldjian AS, Barber RM, Cowling K, York H, et al. Measuring human capital: a systematic analysis of 195 countries and territories, 1990-2016. Lancet. 2018;392:1217–34.

    PubMed  Google Scholar 

  24. Flores EC, Fuhr DC, Bayer AM, Lescano AG, Thorogood N, Simms V. Mental health impact of social capital interventions: a systematic review. Soc Psychiatry Psychiatr Epidemiol. 2018;53:107–19.

    PubMed  Google Scholar 

  25. Luthans F, Youssef-Morgan CM. Psychological capital: an evidence-based positive approach. Annu Rev Organ Psychol Organ Behav. 2017;4:339–66.

    Google Scholar 

  26. Song R, Sun N, Song X. The efficacy of psychological capital intervention (PCI) for depression from the perspective of positive psychology: a pilot study. Front Psychol. 2019;10:1816.

    PubMed  PubMed Central  Google Scholar 

  27. The World Bank. Human Capital Project. 2020. https://www.worldbank.org/en/publication/human-capital.

  28. World Bank. Building human capital starts with health. 2018. World Bank Blogs. Accessed: 17 Oct 2020. https://blogs.worldbank.org/health/building-human-capital-starts-health.

  29. Vigo DV, Patel V, Becker A, Bloom D, Yip W, Raviola G, et al. A partnership for transforming mental health globally. Lancet Psychiatry. 2019;6:350–6.

    PubMed  Google Scholar 

  30. McPherson KE, Kerr S, McGee E, Morgan A, Cheater FM, McLean J, et al. The association between social capital and mental health and behavioural problems in children and adolescents: an integrative systematic review. BMC Psychol. 2014;2:7.

    PubMed  PubMed Central  Google Scholar 

  31. Santamaría-García H, Baez S, Gómez C, Rodríguez-Villagra O, Huepe D, Portela M, et al. The role of social cognition skills and social determinants of health in predicting symptoms of mental illness. Transl Psychiatry. 2020;10:165.

    PubMed  PubMed Central  Google Scholar 

  32. Campbell C. Social capital, social movements and global public health: fighting for health-enabling contexts in marginalised settings. Soc Sci Med. 2019;257:112153.

    PubMed  Google Scholar 

  33. Luthans F. The need for and meaning of positive organizational behavior. J Organ Behav. 2002;23:695–706.

    Google Scholar 

  34. Richards M, Deary I. Cognitive capital in the British birth cohorts: an introduction. Longitud Life Course Stud. 2010;1:197–200.

    Google Scholar 

  35. Chapman SB, Cook LG, Vas AK, Robertson IH. Enhancing human cognitive capital by harnessing the brain’s inherent neuroplasticity. In: Schnyer MDMaDM, editor. Human performance optimization: the science and ethics of enhancing human capabilities. New York City: Oxford University Press; 2012.

  36. Magnuson K, Schindler H. Supporting children’s early development by building caregivers’ capacities and skills: a theoretical approach informed by new neuroscience research. J Fam Theory Rev. 2019;11:59–78.

    Google Scholar 

  37. Pollak S, Wolfe B, Barbara L. How developmental neuroscience can help address the problem of child poverty (March 2020). NBER Working Paper No. w26842. 2020. https://ssrn.com/abstract=3550991.

  38. Manes F. 7 How neuroscience can inform public policy. J Neurol Neurosurg Psychiatry. 2019;90:A3–4.

    Google Scholar 

  39. Healthy brain bonds : is this a feasible option (English). WBG Global Mental Health Initiative Washington, D.C.: World Bank Group; 2018. http://documents.worldbank.org/curated/en/310661533223406666/Healthy-brain-bonds-is-this-a-feasible-option.

  40. Weill Neurohub. https://www.weillneurohub.org/ (2020). Accessed 2020.

  41. Healthy Brains Global Initiative. https://onemind.org/healthy-brains-global-initiative/ (2020). Accessed 2020.

  42. CIRM California’s Stem Cell Agency. 2020. https://www.cirm.ca.gov/.

  43. Wei D, Rose A. Economic impacts of the California Institute for Regenerative Medicine (CIRM): Schaeffer Center for Health Policy and Economics Sol Price School of Public Policy University of Southern California; 2019. https://www.cirm.ca.gov/sites/default/files/CIRM_Economic%20Impact%20Report_10_3_19.pdf.

  44. Fundacion INECO. Institute of Neurosciences and Public Policies. 2020. https://www.fundacionineco.org/en/institutos/instituto-de-neurociencias-y-politicas-publica/.

  45. Iovan S, Lantz PM, Shapiro S. “Pay for success” projects: financing interventions that address social determinants of health in 20 countries. Am J Public Health. 2018;108:1473–7.

    PubMed  PubMed Central  Google Scholar 

  46. Nonprofit Finance Fund. Pay for Success: The First 25. https://nff.org/report/pay-success-first-25 (2019). Accessed 2019.

  47. Social FInance. Career Impact Bonds. https://socialfinance.org/career-impact-bonds/ (2020). Accessed 2020.

  48. Center for BrainHealth. The BrainHealth Project. https://brainhealth.utdallas.edu/the-brainhealth-project/ (2020). Accessed 2020.

  49. Alzheimer’s Drug Discovery Foundation. https://www.alzdiscovery.org/about-addf (2020). Accessed 2020.

  50. Idrus AA. Dementia Discovery Fund reels in $350M for disease-modifying drugs. FierceBiotech. 2018. https://www.fiercebiotech.com/dementia-discovery-fund-reels-350m-for-disease-modifying-drugs. Accessed 17 Oct 2020.

  51. Fernandez J-M, Stein RM, Lo AW. Commercializing biomedical research through securitization techniques. Nat Biotechnol. 2012;30:964–75.

    CAS  PubMed  Google Scholar 

  52. Lo AW, Ho C, Cummings J, Kosik KS. Parallel discovery of Alzheimer’s therapeutics. Sci Transl Med. 2014;6:241cm245.

    Google Scholar 

  53. Smith D. The next generation of leaders advocating for brain health. Lancet Neurol. 2018;17:29–30.

    PubMed  Google Scholar 

  54. WEF. Human capital as an asset: an accounting framework to reset the value of talent in the new world of work. http://www3.weforum.org/docs/WEF_NES_HR4.0_Accounting_2020.pdf (2020). Accessed 2020.

  55. Wernham A, Teutsch SM. Health in All Policies for big cities. J Public Health Manag Pract. 2015;21 Suppl 1:S56–65.

    PubMed  Google Scholar 

  56. Joint action on mental health and well-being: mental Health in All Policies. 2017. European Union. Accessed: 17 Oct 2020. https://www.lisboninstitutegmh.org/assets/docs/publications/MENTAL%20HEALTH%20IN%20ALL%20POLICIES-20200612000831.pdf.

  57. Olivari BS, French ME, McGuire LC. The Public Health Road Map to respond to the growing dementia crisis. Innov Aging. 2020;4:1–11.

    Google Scholar 

  58. The World Bank. About The Human Capital Project. 2020. https://www.worldbank.org/en/publication/human-capital/brief/about-hcp.

  59. World Bank Blogs. How is the Human Capital Index prompting action? https://blogs.worldbank.org/voices/how-human-capital-index-prompting-action (2019). Accessed 2019.

  60. Thompson PM, Jahanshad N, Ching CR, Salminen LE, Thomopoulos SI, Bright J, et al. ENIGMA and global neuroscience: a decade of large-scale studies of the brain in health and disease across more than 40 countries. Transl Psychiatry. 2020;10:1–28.

    Google Scholar 

  61. Dagum P. Digital biomarkers of cognitive function. NPJ Digit Med. 2018;1:1–3.

    Google Scholar 

  62. Torous J, Myrick KJ, Rauseo-Ricupero N, Firth J. Digital mental health and COVID-19: using technology today to accelerate the curve on access and quality tomorrow. JMIR Ment Health. 2020;7:e18848.

  63. Chancellor S, De Choudhury M. Methods in predictive techniques for mental health status on social media: a critical review. NPJ Digit Med. 2020;3:1–11.

    Google Scholar 

  64. Amir S, Dredze M, Ayers JW. Mental health surveillance over social media with digital cohorts. In: Proceedings of the sixth workshop on computational linguistics and clinical psychology. Minneapolis, Minnesota: Association for Computational Linguistics; 2019.

  65. Tran T, Luo W, Phung D, Harvey R, Berk M, Kennedy RL, et al. Risk stratification using data from electronic medical records better predicts suicide risks than clinician assessments. BMC Psychiatry. 2014;14:76.

    PubMed  PubMed Central  Google Scholar 

  66. Karmakar C, Luo W, Tran T, Berk M, Venkatesh S. Predicting risk of suicide attempt using history of physical illnesses from electronic medical records. JMIR Ment Health. 2016;3:e19.

    PubMed  PubMed Central  Google Scholar 

  67. Samerski S. Individuals on alert: digital epidemiology and the individualization of surveillance. Life Sci Soc Policy. 2018;14:13.

    PubMed  PubMed Central  Google Scholar 

  68. Licinio J, Wong ML. Launching the ‘war on mental illness’. Mol Psychiatry. 2014;19:1–5.

    CAS  PubMed  Google Scholar 

  69. Weeramanthri TS, Dawkins HJS, Baynam G, Bellgard M, Gudes O, Semmens JB. Editorial: precision public health. Front Public Health. 2018;6:1–3.

    Google Scholar 

  70. Cosgrove V, Gliddon E, Berk L, Grimm D, Lauder S, Dodd S, et al. Online ethics: where will the interface of mental health and the internet lead us? Int J bipolar Disord. 2017;5:26.

    PubMed  PubMed Central  Google Scholar 

  71. Eyre HA, Ellsworth W, Fu E, Manji H, Berk M. Responsible innovation in technology for mental health care. Lancet Psychiatry. 2020;7:728–30. https://doi.org/10.1016/S2215-0366(20)30192-9.

    PubMed  PubMed Central  Google Scholar 

  72. OECD. Recommendation of the Council on Responsible Innovation in Neurotechnology. Paris, France: OECD; 2020. https://www.oecd.org/science/recommendation-on-responsible-innovation-in-neurotechnology.htm.

  73. Nesta. Innovation Policy Toolkit: introduction to innovation policy and collaboration. https://www.nesta.org.uk/toolkit/innovation-policy-toolkit-introduction-to-innovation-policy-and-collaboration/ (2015). Accessed 2015.

  74. Ternes K, Iyengar V, Lavretsky H, Dawson WD, Booi L, Ibanez A, et al. Brain health INnovation Diplomacy: a model binding diverse disciplines to manage the promise and perils of technological innovation. Int Psychogeriatr. 2020;32:955–79. https://doi.org/10.1017/S1041610219002266.

    PubMed  PubMed Central  Google Scholar 

  75. Jain A. Stanford Brainstorm presents America’s first mental health innovation course. Harv Technol Rev. 2020;3. https://harvardtechnologyreview.com/2020/03/30/stanford-brainstorm-presents-americas-first-mental-health-innovation-course/.

Download references

Acknowledgements

We would like to thank the following individuals for their helpful inputs to this concept and paper: Vikram Patel, Maureen Hackett, Jim Hackett, Bruce Miller, Ian Everall, Jeremy Kranz, Jeff Paine, Mark Heinemeyer, Chase Untermeyer, and Thomas Dougherty.

Funding

KS is supported by NIMH, Training the Science of Child Mental Health Treatment, 5T32MH073517-14. MB is supported by a NHMRC Senior Principal Research Fellowship (1059660 and 1156072). JC is supported by KMA; NIGMS grant P20GM109025; NINDS grant U01NS093334; and NIA grant R01AG053798. No other co-authors have funding support to note. AWL gratefully acknowledges funding support from Jean-Jacques DeGroof and other sponsors of the MIT Laboratory for Financial Engineering (https://lfe.mit.edu/about/sponsors/). No funding bodies of AWL had any role in study design, data collection and analysis, decision to publish, or preparation of this paper. No direct funding was received for this study by AWL, who was personally salaried by his institution during the period of writing (though no specific salary was set aside for or given to AWL for the writing of this paper). DJ’s work was supported, in part, by the National Institute of Mental Health R01 grant (R01MH094151-01 to DJ [PI]), and the Sam and Rose Stein Institute for Research on Aging at the University of California San Diego. WDD reports funding from GBHI ALZ UK-20-640170 and from Oregon Health Authority. HL receives grant funding from NIMH, NIA, NCCIH, NIAMS, PCORI, Alzheimer’s Research and Prevention Foundation. E. Storch reports research support from NIH, Texas Higher Education Coordinating Board, Red Cross, Greater Houston Community Foundation, ReBuild Texas. AI is partially supported by grants from CONICET, ANID/FONDAP/15150012, the Interamerican Development Bank (IDB), GBHI ALZ UK-20-639295, and the Multi-partner Consortium to Expand Dementia Research in Latin America (ReDLat; NIH NIA R01 AG057234, Alzheimer’s Association SG-20-725707, Tau Consortium, and Global Brain Health Institute).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Harris A. Eyre.

Ethics declarations

Conflict of interest

JC has provided consultation to Acadia, Actinogen, Alkahest, Alzheon, AnnovisBio, Avanir, Axsome, BiOasis, Biogen, Cassava, Cerecin, Cortexyme, Cytox, Diadem, EIP Pharma, Eisai, Foresight, GemVax, Genentech, Green Valley, Grifols, Maplight, Merck, Otsuka, Resverlogix, Roche, Samumed, Samus, Signant, Third Rock, and United Neuroscience pharmaceutical and assessment companies. JC has stock options in ADAMAS, MedAvante, QR pharma/AnnovisBio, BiOasis. Ryan Abbott works as an attorney and consult to a variety of commercial enterprises in the life science and information technology fields. AWL reports personal investments in public and private biotech companies, biotech venture capital funds, and biotech mutual funds. He is a director of BridgeBio Pharma and Roivant Sciences, and a member of the Board of Overseers at Beth Israel Deaconess Medical Center and the NIH’s National Center for Advancing Translational Sciences Advisory Council and Cures Acceleration Network Review Board. He is a co-founder and partner of QLS Advisors, a health care analytics company; an advisor to BrightEdge Ventures, the impact fund of the American Cancer Society; and chairman emeritus and senior advisor to AlphaSimplex Group, an asset management company he founded in 1999. CR receives a stipend from the American Association for Geriatric Psychiatry for editing the American Journal of Geriatric Psychiatry; royalty income from the University of Pittsburgh as co-inventor of the Pittsburgh Sleep Quality Inventory. IT reports income and stock in ALTOIDA LLC and has a patent “Apparatus, method and program for determining a cognitive state of a user of a mobile device” pending. HAE receives fees from PRODEO LLC, PreActive Technologies INC and ALTOIDA LLC. CHN had served as a consultant for Lundbeck, Grunbiotics, Servier, Janssen-Cilag, and Eli Lilly, received research grant support from Lundbeck, and speaker honoraria from Servier, Lundbeck, Bristol-Myers Squibb, Organon, Eli Lilly, GlaxoSmithKline, Janssen-Cilag, Astra-Zenaca, Wyeth, and Pfizer. WDD reports personal fees from Commonwealth Fund, personal fees from AARP, personal fees from Insights to Illuminate, LLC, personal fees from Cognitive Solutions, LLC, personal fees from Oregon Health Care Association, personal fees from Mather LifeWays, personal fees from Splaine Consulting, outside the submitted work. E. Storch reports consulting fees from Levo Therapeutics; Honoraria from International OCD Foundation; and book royalties from Wiley, Elsevier, Springer, American Psychological Association, Oxford, Jessica Kingsley, Lawrence Erlbaum. The contents of this publication are solely the responsibility of the authors and do not represent the official views of these Institutions. No other co-authors have disclosures.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smith, E., Ali, D., Wilkerson, B. et al. A Brain Capital Grand Strategy: toward economic reimagination. Mol Psychiatry 26, 3–22 (2021). https://doi.org/10.1038/s41380-020-00918-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41380-020-00918-w

This article is cited by

Search

Quick links